More than 18 million people in the United States have diabetes mellitus, and about 90% of these have the type 2 form of the disease. In addition, between 17 and 40 million people have insulin resistance, impaired glucose tolerance, or the cluster of abnormalities referred to variably as the metabolic syndrome, the dysmetabolic syndrome, syndrome X, or the insulin resistance syndrome. In all of these disorders, a central component of the pathophysiology is insulin resistance, i.e., reduced responsiveness to insulin in tissues such as muscle, fat and liver. Insulin resistance is also closely linked to other common health problems, including obesity, polycystic ovarian disease, hyperlipidemia, hypertension, and atherosclerosis. In this book, we will attempt to dissect the complexity of the molecular mechanisms of insulin action with a special emphasis on those features of the system that are subject to alteration in type 2 diabetes and other insulin resistant states. We explore insulin action at the most basic levels, through complex systems. The book will be appealing to basic and clinical scientists.

Attempts to dissect the complexity of the molecular mechanisms of insulin action with a special emphasis on those features of the system that are subject to alteration in type 2 diabetes and other insulin resistant states

Inhalt
Insulin and IGF-I Receptor Structure and Binding Mechanism.- Subcellular Compartmentalization of Insulin Signaling Processes and GLUT4 Trafficking Events.- Regulation of Insulin Action and Insulin Secretion by SNARE-Mediated Vesicle Exocytosis.- Control of Protein Synthesis by Insulin.- Hepatic Regulation of Fuel Metabolism.- Insulin Action Gene Regulation.- Insulin Action in the Islet ?-Cell.- Central Regulation of Insulin Sensitivity.- Transgenic Models of Impaired Insulin Signaling.- Insulin Resistance.